New research: From Cormac the llama, tiny antibodies against coronavirus
Since the pandemic broke, several researchers have produced llama nanobodies against the SARS-CoV-2 spike protein that may be effective at preventing infections. December 23, 2020 9:05:46 am
Cormac, the llama. (Triple J Farms, Washington/photo provided by NIH)
From a llama named Cormac, researchers at the US National Institutes of Health (NIH) have isolated a set of tiny antibodies, or “nanobodies”, that hold promise against the novel coronavirus SARS-CoV-2. At least one of these nanobodies could prevent infections and detect virus particles by grabbing hold of SARS-CoV-2 spike proteins, the researchers suggest in the journal Scientific Reports. This nanobody, called NIH-CoVnb-112, appeared to work equally well in either liquid or aerosol form, which suggests it could remain effective after inhalation.
WINDOW ROCK, Ariz. The Navajo Nation is reporting 151 new coronavirus cases and seven more deaths related to COVID-19. The latest figures were reported Tuesday by the Navajo Department of Health for the reservation that extends over parts of Arizona, New Mexico and Utah. The Navajo Nation has reported 755 deaths since the pandemic hit. The Health Department says the first doses of the recently approved vaccine made by Moderna have arrived at the Navajo Area Indian Health Service. The Navajo Nation is in a three-week lockdown requiring all residents to stay home except for dealing with
Full-dose blood thinners may harm, not help, COVID-19 patients in ICU
By (0)
A member of the Israeli medical staff treats a patient in the intensive care unit of the COVID-19 ward in the Shaare Tzedek Medical Center in Jerusalem, on Tuesday, October 20, 2020. A new study found that full-dose blood thinners could harm COVID-19 patients in ICU. Photo by Debbie Hill/UPI | License Photo
Because COVID-19 is known to raise the odds for dangerous blood clots, blood thinners have quickly become part of routine care for many hospitalized patients.
But three clinical trials testing full doses of these drugs in COVID-19 patients have now paused recruitment of critically ill patients because the medications could end up doing more harm than good.
Newborns Gain Protection From COVID-19 When Moms Gets Sick in 3rd Trimester - Health Dept. Wed 23rd December 2020 | 12:28 AM
Babies born to women who test positive for the novel coronavirus during the final trimester of pregnancy will most likely be disease free when they enter the world, the US National Institutes of Health (NIH) reported on Tuesday based on a recent study
WASHINGTON (UrduPoint News / Sputnik - 22nd December, 2020) Babies born to women who test positive for the novel coronavirus during the final trimester of pregnancy will most likely be disease free when they enter the world, the US National Institutes of Health (NIH) reported on Tuesday based on a recent study.